Standard Inpatient Cardiac RehabilitationEccentric Cycling Exercise
Standard Inpatient Cardiac Rehabilitation: Standard stage I inpatient cardiac rehabilitation provided after myocardial infarction and individualized according to each participant's clinical condition and exercise capacity. The program includes standard kinesitherapy and exercise-based rehabilitation procedures.
Eccentric Cycling Exercise: Supervised eccentric cycling exercise performed on a motor-driven semi-recumbent cycle ergometer in addition to standard inpatient cardiac rehabilitation. Sessions will last 10 to 30 minutes, with progressive adaptation during the first five sessions. Exercise workload will be individualized according to baseline exercise capacity. Perceived exertion and muscle soreness will be monitored during each session.
Study summary
This clinical trial will evaluate a two-week eccentric exercise program conducted as part of comprehensive cardiac rehabilitation in patients after a heart attack (myocardial infarction). Eccentric exercise involves muscle contractions while the muscles are lengthening and may allow the muscles to work at a relatively high load with a lower cardiovascular and metabolic demand than traditional exercise.
The main aim of the study is to determine whether eccentric exercise affects blood levels of proteins released or regulated in response to physical activity, including musclin, interleukin-6, and myostatin. The study will also evaluate whether the program improves physical performance and functional capacity.
Participants will complete eccentric cycling exercise on a semi-recumbent cycle ergometer during a two-week cardiac rehabilitation program. Blood samples and physical-function measurements will be collected before and after the intervention.
Eligibility
Sex
MALE
Min age
50 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria
* Documented history of myocardial infarction confirmed by medical records.
* Qualification for stage I comprehensive inpatient cardiac rehabilitation.
* Clinically stable condition allowing participation in exercise-based cardiac rehabilitation.
* New York Heart Association functional class I or II.
* Moderate or good exercise tolerance, defined as an exercise capacity of at least 5 metabolic equivalents, assessed during an exercise test.
* No cardiovascular contraindications to exercise testing or participation in exercise-based cardiac rehabilitation.
* Ability to understand the study procedures and follow the instructions provided by the study personnel.
* Provision of written informed consent to participate in the study.
Exclusion Criteria:
* Any contraindication to exercise-based cardiac rehabilitation or exercise testing.
* Acute myocardial infarction within the first 4 days before planned initiation of exercise rehabilitation.
* Unstable angina.
* Significant left main coronary artery stenosis considered a contraindication to exercise by the treating cardiologist.
* Symptomatic cardiac arrhythmias.
* Symptomatic severe aortic stenosis.
* Decompensated heart failure.
* Acute pulmonary embolism or pulmonary infarction.
* Deep vein thrombosis.
* Recent or mobile intracardiac thrombus.
* Acute myocarditis, endocarditis, or pericarditis.
* Aortic dissection.
* Symptomatic acquired second- or third-degree atrioventricular block without appropriate cardiac pacing.
* Poorly controlled arterial hypertension.
* Recent stroke or transient cerebral ischemic event.
* Any acute or uncontrolled non-cardiovascular condition that may interfere with exercise testing or worsen during exercise, including febrile illness, clinically significant electrolyte abnormalities, uncontrolled hyperthyroidism, or clinically significant anemia.
* Physical or cognitive impairment preventing safe completion of the study procedures, exercise testing, or training intervention.
* Inability or unwillingness to provide written informed consent.
Primary outcome measure(s)
Change From Baseline in Serum Musclin Concentration — Baseline and after completion of the 2-week inpatient cardiac rehabilitation program Serum musclin concentration will be measured in fasting venous blood samples using an enzyme-linked immunosorbent assay (ELISA). The outcome will be calculated as the concentration measured after the intervention minus the baseline concentration and reported in ng/mL.
Change From Baseline in Serum Myostatin Concentration — Baseline and after completion of the 2-week inpatient cardiac rehabilitation program Serum myostatin concentration will be measured in fasting venous blood samples using an enzyme-linked immunosorbent assay (ELISA). The outcome will be calculated as the concentration measured after the intervention minus the baseline concentration.
Change From Baseline in Serum Interleukin-6 Concentration — Baseline and after completion of the 2-week inpatient cardiac rehabilitation program Serum interleukin-6 concentration will be measured in fasting venous blood samples using an enzyme-linked immunosorbent assay (ELISA). The outcome will be calculated as the concentration measured after the intervention minus the baseline concentration.
Trial sites (1)
Facility
City
Region
Status
Florian Ceynowa Specialist Hospital in Wejherowo
Wejherowo
Pomeranian Voivodeship
More Medical University of Gdansk trials in Poland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.